Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection

ObjectivesThis study aimed to develop and externally validate a nomogram for predicting liver metastasis after radical resection in patients with pancreatic ductal adenocarcinoma (PDAC).MethodsA total of 247 PDAC patients who underwent radical resection were retrospectively reviewed from January 201...

Full description

Bibliographic Details
Main Authors: Jingshu Tong, Wei Jiang, Shuqi Mao, Shengdong Wu, Caide Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1040411/full
_version_ 1828122374545866752
author Jingshu Tong
Wei Jiang
Shuqi Mao
Shengdong Wu
Caide Lu
author_facet Jingshu Tong
Wei Jiang
Shuqi Mao
Shengdong Wu
Caide Lu
author_sort Jingshu Tong
collection DOAJ
description ObjectivesThis study aimed to develop and externally validate a nomogram for predicting liver metastasis after radical resection in patients with pancreatic ductal adenocarcinoma (PDAC).MethodsA total of 247 PDAC patients who underwent radical resection were retrospectively reviewed from January 2015 to March 2022 at Ningbo Medical Centre Lihuili Hospital Eastern Section, and used as a training cohort to develop the nomogram. 83 PDAC patients from the Ningbo Medical Centre Lihuili Hospital Xingning Section were enrolled as the validation cohort. The postoperative liver metastasis was recorded during the follow-up, and the liver metastasis-free survival was defined as the time from operation to the date of liver metastasis diagnosis or death. The nomogram was established based on independent prognostic factors selected by LASSO and multivariate Cox regression model. The performance was assessed using the concordance index (C-index) and calibration curves. The receiver operating characteristic (ROC) curve and decision curve analysis (DCA) were used to determine the clinical utility of the nomogram model.ResultsFrom the training cohort of 247 patients, a total of 132 patients developed liver metastasis during the follow-up, the 1-, 2- and 3- year liver metastasis-free survival were 52.4%, 43.5% and 40% respectively. The LASSO and multivariate Cox regression analysis indicated that postoperative CA125 (hazard ratio [HR] = 1.007, p <0.001), tumor differentiation (HR = 1.640, p = 0.010), tumor size (HR = 1.520, p = 0.029), lymph node ratio (HR = 1.897, p = 0.002) and portal/superior mesenteric/splenic vein invasion degree (PV/SMV/SV) (HR = 2.829, p <0.001) were the independent factors of liver metastasis. A nomogram with independent factors was developed and the C-index was 0.760 (95% confidence interval [CI], 0.720-0.799) and 0.739 (95% CI, 0.669-0.810) in the training and validation cohorts, respectively. The areas under curve (AUC) of the nomogram at 1-, 2- and 3-year were 0.815, 0.803 and 0.773 in the training cohort, and 0.765, 0.879 and 0.908 in the validation cohort, respectively, higher than those in TNM stage. Decision curve analysis (DCA) analysis revealed that the nomogram model provided superior net benefit in clinical utility. Liver metastasis-free survival curves showed a significant discriminatory ability for liver metastasis risk based on the nomogram (p <0.001).ConclusionsThe nomogram showed high accuracy in predicting liver metastasis for PDAC after radical resection, and may serve as a clinical support tool to guide personalized and prescient intervention.
first_indexed 2024-04-11T14:34:43Z
format Article
id doaj.art-e962599dd9fb42bd85add1e44c3318b9
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T14:34:43Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-e962599dd9fb42bd85add1e44c3318b92022-12-22T04:18:23ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-11-011210.3389/fonc.2022.10404111040411Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resectionJingshu TongWei JiangShuqi MaoShengdong WuCaide LuObjectivesThis study aimed to develop and externally validate a nomogram for predicting liver metastasis after radical resection in patients with pancreatic ductal adenocarcinoma (PDAC).MethodsA total of 247 PDAC patients who underwent radical resection were retrospectively reviewed from January 2015 to March 2022 at Ningbo Medical Centre Lihuili Hospital Eastern Section, and used as a training cohort to develop the nomogram. 83 PDAC patients from the Ningbo Medical Centre Lihuili Hospital Xingning Section were enrolled as the validation cohort. The postoperative liver metastasis was recorded during the follow-up, and the liver metastasis-free survival was defined as the time from operation to the date of liver metastasis diagnosis or death. The nomogram was established based on independent prognostic factors selected by LASSO and multivariate Cox regression model. The performance was assessed using the concordance index (C-index) and calibration curves. The receiver operating characteristic (ROC) curve and decision curve analysis (DCA) were used to determine the clinical utility of the nomogram model.ResultsFrom the training cohort of 247 patients, a total of 132 patients developed liver metastasis during the follow-up, the 1-, 2- and 3- year liver metastasis-free survival were 52.4%, 43.5% and 40% respectively. The LASSO and multivariate Cox regression analysis indicated that postoperative CA125 (hazard ratio [HR] = 1.007, p <0.001), tumor differentiation (HR = 1.640, p = 0.010), tumor size (HR = 1.520, p = 0.029), lymph node ratio (HR = 1.897, p = 0.002) and portal/superior mesenteric/splenic vein invasion degree (PV/SMV/SV) (HR = 2.829, p <0.001) were the independent factors of liver metastasis. A nomogram with independent factors was developed and the C-index was 0.760 (95% confidence interval [CI], 0.720-0.799) and 0.739 (95% CI, 0.669-0.810) in the training and validation cohorts, respectively. The areas under curve (AUC) of the nomogram at 1-, 2- and 3-year were 0.815, 0.803 and 0.773 in the training cohort, and 0.765, 0.879 and 0.908 in the validation cohort, respectively, higher than those in TNM stage. Decision curve analysis (DCA) analysis revealed that the nomogram model provided superior net benefit in clinical utility. Liver metastasis-free survival curves showed a significant discriminatory ability for liver metastasis risk based on the nomogram (p <0.001).ConclusionsThe nomogram showed high accuracy in predicting liver metastasis for PDAC after radical resection, and may serve as a clinical support tool to guide personalized and prescient intervention.https://www.frontiersin.org/articles/10.3389/fonc.2022.1040411/fullpancreatic ductal adenocarcinomanomogramliver metastasisrecurrenceradical resection
spellingShingle Jingshu Tong
Wei Jiang
Shuqi Mao
Shengdong Wu
Caide Lu
Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
Frontiers in Oncology
pancreatic ductal adenocarcinoma
nomogram
liver metastasis
recurrence
radical resection
title Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
title_full Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
title_fullStr Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
title_full_unstemmed Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
title_short Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
title_sort development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
topic pancreatic ductal adenocarcinoma
nomogram
liver metastasis
recurrence
radical resection
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1040411/full
work_keys_str_mv AT jingshutong developmentandvalidationofanomogramtopredictlivermetastasisforpancreaticductaladenocarcinomaafterradicalresection
AT weijiang developmentandvalidationofanomogramtopredictlivermetastasisforpancreaticductaladenocarcinomaafterradicalresection
AT shuqimao developmentandvalidationofanomogramtopredictlivermetastasisforpancreaticductaladenocarcinomaafterradicalresection
AT shengdongwu developmentandvalidationofanomogramtopredictlivermetastasisforpancreaticductaladenocarcinomaafterradicalresection
AT caidelu developmentandvalidationofanomogramtopredictlivermetastasisforpancreaticductaladenocarcinomaafterradicalresection